Is Inozyme Pharma, Inc. (INZY) a Buy, Sell, or Hold?
Inozyme Pharma, Inc.
NASDAQ:INZY
$4 USD
$0.01 (0.25%)
- Volume
- 1.46M
- Average Volume
- 2.21M
- Market Capitalization
- $258.25M
- P/E Ratio
- -2.47
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $6.24
- Year Low
- $0.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.56
Analyst Rating
N/A
0 Rating Score
UPSIDE/DOWNSIDE
-71.4% DOWNSIDE
$14.00 Price Target
UPSIDE/DOWNSIDE HIGH
-75.0% DOWNSIDE
$16.00 Price Target High
UPSIDE/DOWNSIDE LOW
0.0% UPSIDE
$4.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Allison Bratzel | $4 | $3.95 | 2025-05-16 03:48 PM | 1.3% |
| Stifel Nicolaus | Dae Gon Ha | $16 | $5.21 | 2024-09-11 12:18 PM | 207.1% |
| Wells Fargo | Tiago Fauth | $14 | $4.51 | 2024-05-30 01:39 AM | 210.4% |
| H.C. Wainwright | Edward White | $14 | $5.87 | 2024-04-09 02:36 AM | 138.5% |